Short description
Micromet is a biotechnology company focused on the research, development and commercialization of novel biological products.
Description
Micromet is a biotechnology company focused on the research, development and commercialization of novel biological products for the treatment and control of cancer. Their lead product candidate, Canvaxin, is one of a new class of products being developed in the area of specific active immunotherapy, also known as therapeutic cancer vaccines.
Last funding
Cannot Access
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Rockville, Maryland, United States, North America
Founded on
January 1, 1993
Exited on
October 30, 2003
Went public on
October 30, 2003
Delisted on
March 7, 2012
Stock symbol
CNVX
Non-profit?
No
Acquired?
No
Employees count
5001+
Investors
Noaccessforu, Cannot Access, Uh Ohhhh, Absolutely Noaccess, Noaccess, Cannot Access, Nopepepe, Blurry Noaccess, Noway Youcantaccess, Nopepepe, Uh Ohhhh, Uh Ohhhh
Sign in for full access